Keywords: C. trachomatis; 23S rRNA; gyrA; parC; Azithromycin; Sitafloxacin;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Atopic dermatitis; unsupervised cluster analysis; disease heterogeneity; clusters; phenotypes; endotypes; personalized medicine; principal component analysis; AD; Atopic dermatitis; BSA; Body surface area; GRO-α; Growth-regulated oncogene-alpha; ISAC; Im
Keywords: Shigella species; minimal inhibitory concentration (MICs); fluoroquinolone genes; QRDRs; gyrA; gyrB; parC; and parE; genomic DNA; PCR amplification; restriction digestion and shigellosis;
Keywords: Salmonella enterica; Antimicrobial resistance; Quinolone resistance; Mobilisable plasmid; PMQR; Ciprofloxacin; Nalidixic acid; qnrS; gyrA; gyrB; parC; parE;
Determination of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infection in Iran
Keywords: Escherichia coli; Klebsiella pneumoniae; gyrA; parC; Plasmid-mediated quinolone resistance; PMQR genes;
GyrA and/or ParC alterations of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis
Keywords: Haemophilus influenzae; Urethritis; Fluoroquinolone resistance; GyrA; ParC;
Prevalence and mechanisms of resistance to fluoroquinolones in Pseudomonas aeruginosa and Escherichia coli isolates recovered from dogs suffering from otitis in Greece
Keywords: Pseudomonas aeruginosa; Escherichia coli; Fluoroquinolone resistance; GyrA; ParC; PMQR; Canine otitis;
Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016
Keywords: 16S rRNA; 23S rRNA; Antimicrobial resistance; Aptima; Azithromycin; Hologic; Moxifloxacin; Mycoplasma genitalium; parC;
New developments in non-quinolone-based antibiotics for the inhibiton of bacterial gyrase and topoisomerase IV
Keywords: Bacterial gyrase; Topoisomerase IV; Drug resistance; Binding sites; Potency; DNA; deoxyribonucleic acid; ATP; adenosine triphosphate; GyrA; gyrase A subunit; GyrB; gyrase B subunit; ParC; topoisomerase IV C subunit; ParE; topoisomerase IV E subunit; PDB;
New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity
Keywords: Antibacterial; DNA gyrase; GyrB; Inhibitor; N-phenylpyrrolamide; ParE; Topoisomerase IV; ATCC; American type culture collection; ATR; attenuated total reflectance; CDI; 1,1â²-carbonyldiimidazole; CFU; colony-forming unit; CLSI; Clinical and Laboratory St
The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran
Keywords: Pseudomonas aeruginosa; Fluoroquinolone resistance; gyrA; parC
Long-term Course of Depression Trajectories in Patients With COPD
Keywords: COPD; depression; dyspnea; long-term follow-up; new onset; persistent; remittent; 6MWD; 6-min walk distance; CCL18; chemokine (C-C motif) ligand 18; CES-D; Center for Epidemiologic Studies Depression Scale; CRP; C-reactive protein; ECLIPSE; Evaluation of
A molecular analysis of quinolone-resistant Haemophilus influenzae: Validation of the mutations in Quinolone Resistance-Determining Regions
Keywords: Haemophilus influenzae; Quinolone-resistant; GyrA; ParC; Quinolone Resistance-Determining Regions; Moxifloxacin
Molecular Investigation of Quinolone Resistance of Quinolone Resistance-Determining Region in Streptococcus pneumoniae Strains Isolated from Iran Using Polymerase Chain Reaction–Restriction Fragment Length Polymorphism Method
Keywords: gyrA; parC; parE; polymerase chain reaction–restriction fragment length polymorphism; quinolones; Streptococcus pneumoniae
Disease management index of potential years of life lost as a tool for setting priorities in national disease control using OECD health data
Keywords: Setting priorities; Disease burden; Disease management index; DMI; Position value for relative comparison; PARC; Potential years of life lost;
Analysis of plasmid-mediated quinolone resistance genes in clinical isolates of the tribe Proteeae from Argentina: First report of qnrD in the Americas
Keywords: Quinolone; Plasmid-mediated quinolone resistance; qnrD; gyrA; gyrB; parC;
CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases
Keywords: CCL18; Interstitial lung disease; Hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis; Inflammation; Fibrosis; AaO2; alveolar-arterial PO2 difference; AM; alveolar macrophage; AMAC; alternative macrophage activation-associated CC chemokine; ATS/ER
Multiplex Real-Time Polymerase Chain Reaction-Based Method for the Rapid Detection of gyrA and parC Mutations in Quinolone-Resistant Escherichia coli and Shigella spp.
Keywords: fluoroquinolone; gyrA; multiplex real-time PCR; parC
Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU
Keywords: Acinetobacter; GyrA; ParC; Quinolone resistance determining regions
Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India
Keywords: Neisseria gonorrhoeae; Quinolone resistance; Mutations; gyra; parc;
Resistance to Fluoroquinolone by a Combination of Efflux and Target Site Mutations in Enteroaggregative Escherichia coli Isolated in Korea
Keywords: aac(6′)-Ib-cr; efflux pump; enteroaggregative Escherichia coli; fluoroquinolone; gyrA; parC; qnr
Recommendations for the diagnosis and management of Niemann-Pick disease type C: An update
Keywords: ACE; Addenbrooke's Cognitive Examination; ASM; acid sphingomyelinase; ALAT; alanine aminotransferase; ASAT; aspartate aminotransferase; BARS; Brief Ataxia Rating Scale; BPRS; Brief Psychiatric Rating Scale; BSID; Bayley Scales for Infant Development; cDNA
Development of a pyrosequencing assay for rapid assessment of quinolone resistance in Acinetobacter baumannii isolates
Keywords: Acinetobacter baumannii; Quinolone resistance; gyrA; parC; Pyrosequencing;
Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
Keywords: A baumannii; efflux pump fluoroquinolone resistance; gyrA; gyrB; parC
Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance
Keywords: Mycoplasma genitalium; Fluoroquinolone resistance; GyrA; ParC
Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones
Keywords: Bartonella bacilliformis; Quinolones; Resistance; gyrA; parC; Carrion's disease
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan
Keywords: Acinetobacter baumannii; AdeB; GyrA; ParC; Class 1 integron
High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17)
Keywords: vanA; gyrA; parC; CC17; Enterococcus
The use of space availability information in “PARC” systems to reduce search times in parking facilities
Keywords: Parking; Parking facilities; PARC; Behaviour; Choice model
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide
Keywords: p53; PARC; TAT; Apoptosis; Etoposide
Echinococcus multilocularis: Inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis
Keywords: AE; alveolar echinococcosis; CCL; CC chemokine ligand; CCR; CC chemokine receptor; GRO-α; growth related oncogene, alpha; LARC; liver and activation regulated chemokine; MCP-3; monocyte chemoattractant protein 3; MCP-4; monocyte chemoattractant protein 4
Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing® technology
Keywords: gyrA; parC; Pyrosequencing; Quinolone resistance; Salmonella enterica;
Diesel exhaust exposure favors TH2 cell recruitment in nonatopic subjects by differentially regulating chemokine production
Keywords: Diesel; chemokines; allergy; asthma; air pollution; DEP; Diesel exhaust particle; DEP-PAH; Diesel exhaust particles-polyaromatic hydrocarbons; IP-10; IFN-γ-induced protein 10; MDC; Macrophage-derived chemokine; MIG; Monokine induced by IFN-γ; PARC;
A novel p53-binding domain in CUL7
Keywords: Cullin RING ligase; SKP-cullin-F box; CUL7; p53; PARC; Ubiquitin-protein ligases; Sequence homology; Tumor suppressors
Impact of Induction Concurrent Chemoradiotherapy on Pulmonary Function and Postoperative Acute Respiratory Complications in Esophageal Cancer
Keywords: diffusion capacity of the lung for carbon monoxide; esophageal cancer; postoperative acute respiratory complication; pulmonary function; radiation therapy; cCRT; concurrent chemoradiotherapy; Dlco; diffusion capacity of the lung for carbon monoxide; %FEV1
Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa
Keywords: P. aeruginosa; Ciprofloxacin resistance; GyrA; GyrB; ParC; ParE;
Cytokine interactions in mesenchymal stem cells from cord blood
Keywords: Mesenchymal stem cell; Cord blood; Cytokine; Interleukin-1β; Interleukin-6; MCP; monocyte chemotactic protein; IGFBP; insulin-like growth factor binding protein; ENA-78; epithelial neutrophil-activating protein 78; GRO; growth-related oncogene; OSM; onco